Download PDF
Am J Perinatol 2024; 41(07): 915-923
DOI: 10.1055/a-1788-5025
Original Article

Viscoelastic Testing in an Obstetric Population at High Risk of Hemorrhage

Stephen M. Graves 
1   Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio
,
Lauren Montemorano
2   Department of Obstetrics and Gynecology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin
,
Kara M. Rood
1   Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio
,
Maged M. Costantine 
1   Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio
,
Kasey Fiorini
3   Department of Anesthesiology, The Ohio State University College of Medicine, Columbus, Ohio
,
Michael Cackovic
1   Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio
› Author Affiliations Funding The project was funded by the Department of Obstetrics and Gynecology at the Ohio State University. The ROTEM delta analyzer device was borrowed from Instrumentation Laboratory for the conduct of this work.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Introduction Rotational thromboelastometry (ROTEM) is a point-of-care viscoelastic test used in trauma for goal-directed transfusion. However, there are limited data on baseline ROTEM parameters in the U.S. obstetric population. Obtaining baseline parameters is a first step in implementing a goal-directed massive transfusion protocol in obstetric hemorrhage.

Objective Our study aimed to establish pre- and postdelivery baseline parameters in a high-risk obstetric population and determine their association with postpartum hemorrhage (PPH).

Study Design Prospective observational study of patients ≥34 weeks' gestation, at high risk of PPH, admitted for delivery. INTEM, EXTEM, FIBTEM, and APTEM assays were performed at the time of admission to labor and delivery and then 2 hours after delivery. Primary outcome was pre- and postdelivery ROTEM parameters among women without PPH. A sample size of 60 women was needed for >90% power to detect at least 50% correlation between pre- and postdelivery assuming a loss of 10% of participants to follow-up.

Results Of 60 women in the study, 10 (17%) had PPH. Baseline characteristics were not different between those with or without PPH. Pre- and postdelivery ROTEM parameters were not significantly different except for APTEM. None of the patients who had PPH, compared with 4 (10%) of those who did not, had shortened clotting time and higher maximum clot firmness in postdelivery APTEM compared with EXTEM, a pattern suggestive of hyperfibrinolysis (p = 0.4).

Conclusion In this study, we describe baseline ROTEM parameters in women at high risk of PPH. The majority of patients did not have a ROTEM pattern that is suggestive of hyperfibrinolysis, for which tranexamic acid is thought to be beneficial. Based on our findings, previously established obstetric transfusion thresholds for goal-directed massive transfusion protocols are likely valid for the majority of the obstetric population regardless of the presence of comorbidities or pregnancy complications.

Key Points

  • ROTEM parameters do not vary significantly before and after delivery.

  • Most patients did not have a hyperfibrinolysis pattern, for which tranexamic acid is thought to be beneficial.

  • Previous goal-directed obstetric transfusion thresholds are likely valid in most populations.

Keywords

postpartum hemorrhage - viscoelastic testing - ROTEM - maternal mortality

Clinical Trial

Clinical Trial Registered at ClinicalTrials.gov, ID#: NCT04409015, https://clinicaltrials.gov/ct2/show/NCT04409015.




Publication History

Received: 15 November 2021

Accepted: 17 February 2022

Accepted Manuscript online:
04 March 2022

Article published online:
27 May 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesthesiol 2015; 28 (03) 275-284
    CrossrefPubMedGoogle Scholar
  • 2 Henriquez DDCA, Bloemenkamp KWM, van der Bom JG. Management of postpartum hemorrhage: how to improve maternal outcomes?. J Thromb Haemost 2018; 16 (08) 1523-1534
    CrossrefPubMedGoogle Scholar
  • 3 Shaylor R, Weiniger CF, Austin N. et al. National and international guidelines for patient blood management in obstetrics: a qualitative review. Anesth Analg 2017; 124 (01) 216-232
    CrossrefPubMedGoogle Scholar
  • 4 Shields LE, Goffman D, Caughey AB. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: postpartum hemorrhage. Obstet Gynecol 2017; 130 (04) e168-e186
    CrossrefPubMedGoogle Scholar
  • 5 Snegovskikh D, Souza D, Walton Z. et al. Point-of-care viscoelastic testing improves the outcome of pregnancies complicated by severe postpartum hemorrhage. J Clin Anesth 2018; 44: 50-56
    CrossrefPubMedGoogle Scholar
  • 6 de Lange NM, van Rheenen-Flach LE, Lancé MD. et al. Peri-partum reference ranges for ROTEM(R) thromboelastometry. Br J Anaesth 2014; 112 (05) 852-859
    CrossrefPubMedGoogle Scholar
  • 7 Whiting P, Al M, Westwood M. et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess 2015; 19 (58) 1-228 , v–vi
    CrossrefPubMedGoogle Scholar
  • 8 Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev 2016; 2016 (08) CD007871
    PubMedGoogle Scholar
  • 9 Lyndon A, Lagrew D, Shields LE, Main E. . Improving Health Care Response to Obstetric Hemorrhage Version 2.0 CMQCC OBSTETRIC HEMORRHAGE TOOLKIT Version 2.0 3/24/15 2 ACKNOWLEDGEMENTS. CA:CMQCC;2015
    PubMed
  • 10 RStudio Team. RStudio: Integrated Development Environment for R. 2020 . Accessed March 14, 2022 at: https://www.rstudio.com/
    PubMedGoogle Scholar
  • 11 Gall LS, Brohi K, Davenport RA. Diagnosis and treatment of hyperfibrinolysis in trauma (a European perspective). Semin Thromb Hemost 2017; 43 (02) 224-234
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Schöchl H, Frietsch T, Pavelka M, Jámbor C. H S. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009; 67 (01) 125-131
    CrossrefPubMedGoogle Scholar
  • 13 Shamshirsaz AA, Fox KA, Erfani H. et al. Trimester-specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state. Int J Lab Hematol 2021; 43 (05) 1216-1224
    CrossrefPubMedGoogle Scholar
  • 14 Lee J, Eley VA, Wyssusek KH. et al. Baseline parameters for rotational thromboelastometry in healthy labouring women: a prospective observational study. BJOG 2020; 127 (07) 820-827
    CrossrefPubMedGoogle Scholar
  • 15 Gootjes DV, Kuipers I, Thomassen BJW. et al. ROTEM reference ranges in a pregnant population from different nationalities/ethnic backgrounds. Int J Lab Hematol 2019; 41 (05) e99-e103
    CrossrefPubMedGoogle Scholar
  • 16 van Rheenen-Flach LE, Zweegman S, Boersma F, Lenglet JE, Twisk JWR, Bolte AC. A prospective longitudinal study on rotation thromboelastometry in women with uncomplicated pregnancies and postpartum. Aust N Z J Obstet Gynaecol 2013; 53 (01) 32-36
    CrossrefPubMedGoogle Scholar
  • 17 Armstrong S, Fernando R, Ashpole K, Simons R, Columb M. Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. Int J Obstet Anesth 2011; 20 (04) 293-298
    CrossrefPubMedGoogle Scholar
  • 18 Huissoud C, Carrabin N, Benchaib M. et al. Coagulation assessment by rotation thrombelastometry in normal pregnancy. Thromb Haemost 2009; 101 (04) 755-761
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Lee J, Eley VA, Wyssusek KH. et al. Baseline parameters for rotational thromboelastometry (ROTEM®) in healthy women undergoing elective caesarean delivery: a prospective observational study in Australia. Int J Obstet Anesth 2019; 38: 10-18
    CrossrefPubMedGoogle Scholar
  • 20 Pacheco LD, Hankins GDV, Saad AF, Costantine MM, Chiossi G, Saade GR. Tranexamic acid for the management of obstetric hemorrhage. Obstet Gynecol 2017; 130 (04) 765-769
    CrossrefPubMedGoogle Scholar